CD BioSciences, a prominent biotech company, has recently unveiled its latest and innovative service on cytoskeleton-based tumor marker development. This groundbreaking service can be utilized for preclinical tests to determine the tumor type and predict disease progression. The cytoskeleton refers to the network of protein filaments within cells that [...]
Recently, CD BioSciences has announced the release of marine drug development services aiming to move forward the frontier of this area. Utilizing cutting-edge marine biological analysis techniques and unique platforms, CD BioSciences provides customers with tailored research services to produce efficient marine pharmaceutical products for cancer therapies. “Our [...]
MUC1, a protein draped in a shimmering cloak of sugar chains, plays a dual role in our lives: guardian of the inner sanctum in healthy cells and, paradoxically, a mischievous accomplice in the dance of cancer. Unraveling its secrets requires us to delve into the intricate world of mucus, cellular [...]